{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T15:34:45Z","timestamp":1771342485487,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Experimental Immunology Training Grant","award":["#4T32AI007508"],"award-info":[{"award-number":["#4T32AI007508"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.virol.2017.12.016","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T16:28:49Z","timestamp":1514392129000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding"],"prefix":"10.1016","volume":"515","author":[{"given":"Natalie F.","family":"Nidetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom M.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.12.016_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s001090050236","article-title":"Interferons impair early transgene expression by adenovirus-mediated gene transfer in muscle cells","volume":"76","author":"Acsadi","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.virol.2017.12.016_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virol.2017.12.016_bib3","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1128\/jvi.67.9.5198-5205.1993","article-title":"Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells","volume":"67","author":"Bai","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.virol.2011.01.019","article-title":"Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome","volume":"412","author":"Barlan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.12.016_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.01265-10","article-title":"Adenovirus membrane penetration activates the NLRP3 inflammasome","volume":"85","author":"Barlan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chom.2013.07.005","article-title":"Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors","volume":"14","author":"Bhattacharyya","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2017.12.016_bib7","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5: Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2017.12.016_bib8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1538-7836.2010.03752.x","article-title":"Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood","volume":"8","author":"Ekman","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.virol.2017.12.016_bib9","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.1128\/JVI.00593-09","article-title":"Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus","volume":"83","author":"Finn","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2005.09.024","article-title":"The interferon response circuit: induction and suppression by pathogenic viruses","volume":"344","author":"Haller","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.12.016_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/hum.2014.001","article-title":"Innate immunity to adenovirus","volume":"25","author":"Hendrickx","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virol.2017.12.016_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2004.11.014","article-title":"In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity","volume":"332","author":"Hsu","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.12.016_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.vaccine.2013.11.055","article-title":"Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression","volume":"32","author":"Johnson","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.12.016_bib14","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","article-title":"Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity","volume":"188","author":"Johnson","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.12.016_bib15","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.vaccine.2010.06.050","article-title":"Potent immune responses and in vitro pro-inflammatory cytokine suppression by a novel adenovirus vaccine vector based on rare human serotype 28","volume":"28","author":"Kahl","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.12.016_bib16","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/JVI.02702-13","article-title":"Adenovirus detection by the cGAS\/STING\/TBK1 DNA sensing cascade","volume":"88","author":"Lam","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2094","article-title":"Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake","volume":"9","author":"Liang","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virol.2017.12.016_bib18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4049\/jimmunol.1000338","article-title":"CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling","volume":"185","author":"Lindsay","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.12.016_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/jb.91.2.803-812.1966","article-title":"Biophysical studies of vesicular stomatitis virus","volume":"91","author":"McCombs","year":"1966","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.virol.2017.12.016_bib20","doi-asserted-by":"crossref","first-page":"10806","DOI":"10.1128\/JVI.00675-11","article-title":"Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species","volume":"85","author":"McGuire","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cels.2015.06.002","article-title":"The AXL receptor is a sensor of ligand spatial heterogeneity","volume":"1","author":"Meyer","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.virol.2017.12.016_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.chom.2011.03.012","article-title":"The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry","volume":"9","author":"Morizono","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2017.12.016_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1566523044578077","article-title":"Promoters and control elements: designing expression cassettes for gene therapy","volume":"v. 4","author":"Papadakis","year":"2004","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.virol.2017.12.016_bib24","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2006-04-008532","article-title":"Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes","volume":"108","author":"Parker","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.virol.2017.12.016_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.virol.2017.12.016_bib26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2007.10.034","article-title":"TAM receptors are pleiotropic inhibitors of the innate immune response","volume":"131","author":"Rothlin","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.virol.2017.12.016_bib27","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/JVI.79.12.7478-7491.2005","article-title":"Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib28","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/1535-7163.MCT-10-0332","article-title":"Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy","volume":"9","author":"Short","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.virol.2017.12.016_bib29","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1128\/JVI.00557-08","article-title":"Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport","volume":"82","author":"Smith","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.chom.2007.12.001","article-title":"Mechanism of adenovirus neutralization by Human alpha-defensins","volume":"3","author":"Smith","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2017.12.016_bib31","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"Teigler","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF01318064","article-title":"Biophysical properties of virions of human adenovirus of the type 6 and its DNA","volume":"62","author":"Tikchonenko","year":"1979","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib33","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and mer, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2017.12.016_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/jvi.56.2.439-448.1985","article-title":"Molecular composition of the adenovirus type 2 virion","volume":"56","author":"van Oostrum","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.virol.2017.12.016_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virol.2017.12.016_bib37","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib38","doi-asserted-by":"crossref","first-page":"e1000808","DOI":"10.1371\/journal.ppat.1000808","article-title":"A capsid-encoded PPxY-motif facilitates adenovirus entry","volume":"6","author":"Wodrich","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2017.12.016_bib39","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.12.016_bib40","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221730421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221730421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:44:18Z","timestamp":1758588258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221730421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":40,"alternative-id":["S004268221730421X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.12.016","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of type I interferon responses by adenovirus serotype-dependent Gas6 binding","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}